CenExel Clinical Research Acquires CITrials
Psychiatric Specialty Research Facilities in Southern California Join the CenExel Centers of Excellence
News provided by
Share this article
Share this article
SALT LAKE CITY, March 9, 2021 /PRNewswire/ CenExel Clinical Research, Inc., ( CenExel ) announces the acquisition of CITrials, a southern California-based clinical research firm with three sites serving Los Angeles, Orange, and Riverside/San Bernardino counties. CITrials conducts Phase I through Phase IV studies in mental health and internal medicine disorders, with adolescent, adult, and geriatric populations.
(PRNewsfoto/CenExel Clinical Research)
This strategic acquisition allows CenExel to augment its core strength in psychiatric and neurological research and provides further integration opportunities with Anaheim Clinical Trials (ACT), another Center of Excellence site in southern California.